Tata Consultancy Services Ltd.

BSE: 532540 | NSE: TCS
Large Cap | IT - Software
3185.15
60.10 (1.92%)
< Home < Back

TCS launches CCT Platform on its Advanced Drug Development Suite

Date: 17-10-2017

Tata Consultancy Services (TCS) has launched Connected Clinical Trials (CCT), an innovative Software as a Service (SaaS) platform that enables pharmaceutical companies to significantly transform patient engagement in clinical trials and improve the efficiency and accountability of the clinical supply process.

CCT is part of TCS’ Advanced Drug Development (ADD) suite that offers a wide range of cloud based clinical services, including Clinical Data Management, Metadata Management, Pharmacovigilance, and Data Analytics and Insights.

ADD is powered by a cognitive engine called ‘Decision Fabric’ that enables automation of complex business processes. ADD leverages the best of cloud architecture and intuitive user experience design in compliance with good clinical practice quality guidelines (GCP) and privacy regulations.

Tata Consultancy Services (TCS) is an IT services, consulting and business solutions organization that delivers real results to global business, ensuring a level of certainty no other firm can match. The company offers a consulting-led, integrated portfolio of IT, BPS, infrastructure, engineering and assurance services.